Margaret T. Lee, MD

Pediatric Hematology-Oncology
Cancer Care, Pediatrics
More specialties
Accepting New Patients
Treats Children
Virtual Visits/Telehealth
Profile Headshot

Overview

Margaret T. Lee, MD cares for children with blood disorders, such as anemias (sickle cell anemia, thalassemia, and iron deficiency), bleeding (including idiopathic thrombocytopenic purpura [ITP], hemophilia, and von Willebrand disease), and clotting disorders (such as deep vein thrombosis).

Dr. Lee's main research focus is sickle cell disease. She is seeking new ways to prevent the complications of sickle cell disease, particularly those affecting the brain and lungs. Currently, she is investigating whether high-dose vitamin D therapy can reduce respiratory complications in children with sickle cell disease. In addition to its well-known role in maintaining healthy bones, vitamin D has been shown to have anti-infective and anti-inflammatory effects that may benefit patients with sickle cell disease. Dr. Lee is also the site investigator for the National Institutes of Health-funded series of multicenter clinical trials on stroke prevention in children with sickle cell anemia (STOP 1 and 2, SWiTCH, and TWiTCH).

Dr. Lee's other area of interest is a rare group of diseases called vascular anomalies. There is relatively little known about these disorders, and the care of patients with vascular anomalies requires a multidisciplinary group of physicians from several specialties (dermatology, surgery, cardiology, neurology, and hematology/oncology)-all of whom are available at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Hematologists play a role in the medical treatment of vascular tumors and the supportive care of clotting and bleeding complications that are associated with some types of vascular malformations. Dr. Lee is an active participant in the Vascular Anomalies Group at NYP/Morgan Stanley Children's Hospital, as well as the Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology, which is looking at novel therapies for vascular anomalies and their complications.

Areas of Expertise / Conditions Treated

  • Arteriovenous Malformation (AVM)
  • Bannayan-Riley-Ruvalcaba syndrome (BRRS)
  • Bleeding Disorder
  • Blue Rubber Bleb Nevus Syndrome
  • Hemangioma
  • Hemostasis
  • Hereditary Hemorrhagic Telangiectasia (HHT)
  • Kaposiform Hemangioendothelioma
  • Klippel Trenaunay Syndrome
  • Lymphangioma
  • Lymphatic Malformation
  • Lymphedema
  • Parkes-Weber syndrome
  • PIK3-related Overgrowth Spectrum (PROS, CLOVES, MC
  • Proteus Syndrome
  • PTEN-related overgrowth syndrome
  • Sickle Cell Anemia
  • Thrombosis
  • Tufted Angioma
  • Vascular Anomaly
  • Vascular Birthmark
  • Vascular Malformation
  • Vascular Tumor

Academic Appointments

  • Associate Professor of Pediatrics at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Morgan Stanley Children's Hospital

Gender

  • Female

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

15 North Broadway
White Plains, NY 10601
161 Fort Washington Avenue
New York, NY 10032

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Santo Tomas (Philippines)
  • Residency: New York University Medical Center
  • Fellowship: New York University Medical Center

Board Certifications

  • Pediatric Hematology-Oncology

Research

Clinical Trials

NCT02187003 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Evaluate The Efficacy And Safety Of Rivipansel (Gmi-1070) In The Treatment Of Vaso-occlusive Crisis In Hospitalized Subjects With Sickle Cell Disease

NCT02433158 An Open-label Extension Study To Evaluate The Safety Of Rivipansel (Gmi-1070) In The Treatment Of One Or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease

COMPLETED

NCT01276587 Pilot Study of Vitamin D Therapy to Prevent Respiratory Complications in Children With Sickle Cell Disease